Raymond James Financial Services Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-551
| Closed | -$21K | – | 3140 |
|
|
2020
Q4 | $21K | Sell |
551
-8,581
| -94% | -$327K | ﹤0.01% | 2926 |
|
|
2020
Q3 | $493K | Buy |
9,132
+79
| +0.9% | +$4.27K | ﹤0.01% | 1968 |
|
|
2020
Q2 | $2.28M | Sell |
9,053
-2,163
| -19% | -$545K | 0.01% | 1057 |
|
|
2020
Q1 | $1.76M | Buy |
11,216
+1,071
| +11% | +$168K | 0.01% | 946 |
|
|
2019
Q4 | $1.66M | Sell |
10,145
-149
| -1% | -$24.4K | 0.01% | 1256 |
|
|
2019
Q3 | $1.5M | Buy |
10,294
+170
| +2% | +$24.8K | 0.01% | 1249 |
|
|
2019
Q2 | $2.11M | Sell |
10,124
-32
| -0.3% | -$6.65K | 0.01% | 1082 |
|
|
2019
Q1 | $2.12M | Sell |
10,156
-1,629
| -14% | -$340K | 0.01% | 1033 |
|
|
2018
Q4 | $2.07M | Sell |
11,785
-1,663
| -12% | -$291K | 0.01% | 883 |
|
|
2018
Q3 | $3.05M | Sell |
13,448
-820
| -6% | -$186K | 0.01% | 855 |
|
|
2018
Q2 | $2.16M | Buy |
14,268
+119
| +0.8% | +$18K | 0.01% | 975 |
|
|
2018
Q1 | $2.59M | Sell |
14,149
-352
| -2% | -$64.4K | 0.01% | 821 |
|
|
2017
Q4 | $3.09M | Sell |
14,501
-316
| -2% | -$67.3K | 0.02% | 726 |
|
|
2017
Q3 | $3.18M | Buy |
14,817
+608
| +4% | +$130K | 0.02% | 714 |
|
|
2017
Q2 | $2.69M | Buy |
14,209
+746
| +6% | +$141K | 0.02% | 751 |
|
|
2017
Q1 | $3.33M | Buy |
13,463
+704
| +6% | +$174K | 0.03% | 616 |
|
|
2016
Q4 | $3.23M | Buy |
12,759
+767
| +6% | +$194K | 0.03% | 583 |
|
|
2016
Q3 | $2.44M | Buy |
11,992
+3,167
| +36% | +$645K | 0.02% | 676 |
|
|
2016
Q2 | $792K | Sell |
8,825
-336
| -4% | -$30.2K | 0.01% | 1162 |
|
|
2016
Q1 | $497K | Buy |
9,161
+4,472
| +95% | +$243K | 0.01% | 1255 |
|
|
2015
Q4 | $232K | Buy |
+4,689
| New | +$232K | ﹤0.01% | 1492 |
|